Human Immunodeficiency Virus-Associated Obstructive Lung Diseases

Clinics in Chest Medicine

Volumn 34, Issue 2, 2013, Pages 273-282

  Gingo, Matthew R ^a   Morris, Alison ^a   Crothers, Kristina ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

AIDS; Asthma; Chronic obstructive pulmonary disease; Emphysema; HIV; Smoking related lung disease

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; FLUTICASONE; RITONAVIR;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CUSHING SYNDROME; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFLAMMATION; LUNG EMPHYSEMA; METABOLIC DISORDER; MICROBIAL COLONIZATION; MORBIDITY; OSTEOPOROSIS; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SMOKING CESSATION; VIRUS LOAD;

ASTHMA; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING;

EID: 84878135234     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2013.02.002     Document Type: Review

References (78)

1. Gibson P.G., Simpson J.L. The overlap syndrome of asthma and COPD: what are its features and how important is it?. Thorax 2009, 64(8):728-735.
2. Akinbami L.J., Moorman J.E., Bailey C., et al. Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010. NCHS Data Brief 2012, (94):1-8.
3. Kazani S., Israel E. Update in asthma 2011. Am J Respir Crit Care Med 2012, 186(1):35-40.
4. Thun M.J., Carter B.D., Feskanich D., et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med 2013, 368(4):351-364.
5. Vestbo J., Hurd S.S., Agusti A.G., et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, GOLD executive summary. Am J Respir Crit Care Med 2013, 187(4):347-365.
6. Haraguchi M., Shimura S., Hida W., et al. Pulmonary function and regional distribution of emphysema as determined by high-resolution computed tomography. Respiration 1998, 65(2):125-129.
7. Park K.J., Bergin C.J., Clausen J.L. Quantitation of emphysema with three-dimensional CT densitometry: comparison with two-dimensional analysis, visual emphysema scores, and pulmonary function test results. Radiology 1999, 211(2):541-547.
8. Mannino D.M. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest 2002, 121(Suppl 5):121S-126S.
9. Sandford A.J., Silverman E.K. Chronic obstructive pulmonary disease. 1: susceptibility factors for COPD the genotype-environment interaction. Thorax 2002, 57(8):736-741.
10. Chapman K.R. Chronic obstructive pulmonary disease: are women more susceptible than men?. Clin Chest Med 2004, 25(2):331-341.
11. Silverman E.K., Weiss S.T., Drazen J.M., et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 162(6):2152-2158.
12. Petty T.L., Weinmann G.G. Building a national strategy for the prevention and management of and research in chronic obstructive pulmonary disease. National Heart, Lung, and Blood Institute Workshop Summary. Bethesda, Maryland, August 29-31, 1995. JAMA 1997, 277(3):246-253.
13. Rosen M.J., Lou Y., Kvale P.A., et al. Pulmonary function tests in HIV-infected patients without AIDS. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med 1995, 152(2):738-745.
14. Diaz P.T., King M.A., Pacht E.R., et al. The pathophysiology of pulmonary diffusion impairment in human immunodeficiency virus infection. Am J Respir Crit Care Med 1999, 160(1):272-277.
15. Mitchell D.M., Fleming J., Pinching A.J., et al. Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients. Am Rev Respir Dis 1992, 146(3):745-751.
16. Nieman R.B., Fleming J., Coker R.J., et al. Reduced carbon monoxide transfer factor (TLCO) in human immunodeficiency virus type I (HIV-I) infection as a predictor for faster progression to AIDS. Thorax 1993, 48(5):481-485.
17. Shaw R.J., Roussak C., Forster S.M., et al. Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis. Thorax 1988, 43(6):436-440.
18. Diaz P.T., Clanton T.L., Pacht E.R. Emphysema-like pulmonary disease associated with human immunodeficiency virus infection. Ann Intern Med 1992, 116(2):124-128.
19. Diaz P.T., King M.A., Pacht E.R., et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000, 132(5):369-372.
20. Crothers K., Butt A.A., Gibert C.L., et al. Increased COPD among HIV-positive compared to HIV-negative veterans. Chest 2006, 130(5):1326-1333.
21. Crothers K., Huang L., Goulet J.L., et al. HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era. Am J Respir Crit Care Med 2011, 183(3):388-395.
22. George M.P., Kannass M., Huang L., et al. Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS One 2009, 4(7):e6328.
23. Gingo M.R., George M.P., Kessinger C.J., et al. Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. Am J Respir Crit Care Med 2010, 182(6):790-796.
24. Cui Q., Carruthers S., McIvor A., et al. Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study. AIDS Res Ther 2010, 7:6.
25. Hirani A., Cavallazzi R., Vasu T., et al. Prevalence of obstructive lung disease in HIV population: a cross sectional study. Respir Med 2011, 105(11):1655-1661.
26. Drummond M.B., Kirk G.D., Astemborski J., et al. Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax 2012, 67(4):309-314.
27. Kristoffersen U.S., Lebech A.M., Mortensen J., et al. Changes in lung function of HIV-infected patients: a 4.5-year follow-up study. Clin Physiol Funct Imaging 2012, 32(4):288-295.
28. Drummond M.B., Merlo C.A., Astemborski J., et al. The effect of HIV infection on longitudinal lung function decline among injection drug users: a prospective cohort. AIDS 2013, [Epub ahead of print].
29. Crothers K, Kleerup EC, Wongtrakool C, et al. HIV infection is associated with impaired pulmonary diffusing capacity. CROI 2012. Seattle, Mar 7, 2012 (Meeting Abstracts).
30. Gingo M.R., Morris A. Pathogenesis of HIV and the lung. Curr HIV/AIDS Rep 2013, 10(1):42-50.
31. Crothers K., Huang L. Pulmonary complications of immune reconstitution inflammatory syndromes in HIV-infected patients. Respirology 2009, 14(4):486-494.
32. Mori S., Levin P. A brief review of potential mechanisms of immune reconstitution inflammatory syndrome in HIV following antiretroviral therapy. Int J STD AIDS 2009, 20(7):447-452.
33. Morris A., Alexander T., Radhi S., et al. Airway obstruction is increased in pneumocystis-colonized human immunodeficiency virus-infected outpatients. J Clin Microbiol 2009, 47(11):3773-3776.
34. Kling H.M., Shipley T.W., Patil S.P., et al. Relationship of Pneumocystis jirovecii humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection. Infect Immun 2010, 78(10):4320-4330.
35. Shipley T.W., Kling H.M., Morris A., et al. Persistent Pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS. J Infect Dis 2010, 202(2):302-312.
36. Christensen P.J., Preston A.M., Ling T., et al. Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice. Infect Immun 2008, 76(8):3481-3490.
37. Morris A., George M.P., Crothers K., et al. HIV and chronic obstructive pulmonary disease: is it worse and why?. Proc Am Thorac Soc 2011, 8(3):320-325.
38. Ireland A.W., Ghedin E., Pop M., et al. Comparison of the respiratory microbiome in HIV-infected and HIV-uninfected individuals. Am J Respir Crit Care Med 2012, 185(Meeting Abstracts):A4045.
39. Twigg H.L., Nelson D., Dong Q., et al. Analysis of the respiratory microbiome using bronchoalveolar lavage from HIV-infected and uninfected subjects. Am J Respir Crit Care Med 2010, 181(Meeting Abstracts):A5629.
40. Twigg H.L., Nelson D., Dong Q., et al. Analysis of the respiratory microbiome using bronchoalveolar lavage from HIV-infected and uninfected subjects. Am J Respir Crit Care Med 2011, 183(Meeting Abstracts):A6257.
41. Lozupone C., Cota-Gomez A., Palmer B.E., et al. Widespread colonization of the lung by tropheryma whipplei in HIV infection. Am J Respir Crit Care Med 2013, [Epub ahead of print].
42. Pac A., Tobiasz-Adamczyk B., Brzyska M., et al. The role of different predictors in 20-year mortality among Krakow older citizens. Arch Gerontol Geriatr 2013, 56(3):524-530.
43. Poirier C.D., Inhaber N., Lalonde R.G., et al. Prevalence of bronchial hyperresponsiveness among HIV-infected men. Am J Respir Crit Care Med 2001, 164(4):542-545.
44. Wallace J.M., Stone G.S., Browdy B.L., et al. Nonspecific airway hyperresponsiveness in HIV disease. Pulmonary Complications of HIV Infection Study Group. Chest 1997, 111(1):121-127.
45. Foster S.B., Paul M.E., Kozinetz C.A., et al. Prevalence of asthma in children and young adults with HIV infection. J Allergy Clin Immunol 2007, 119(3):750-752.
46. Foster S.B., McIntosh K., Thompson B., et al. Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study. J Allergy Clin Immunol 2008, 122(1):159-165.
47. Gutin F., Butt A., Alame W., et al. Asthma in immune-competent children with human immunodeficiency virus. Ann Allergy Asthma Immunol 2009, 102(5):438.
48. Gingo M.R., Wenzel S.E., Steele C., et al. Asthma diagnosis and airway bronchodilator response in HIV-infected patients. J Allergy Clin Immunol 2012, 129(3):708-714.e8.
49. Bridevaux P.O., Probst-Hensch N.M., Schindler C., et al. Prevalence of airflow obstruction in smokers and never-smokers in Switzerland. Eur Respir J 2010, 36(6):1259-1269.
50. Appleton S.L., Adams R.J., Wilson D.H., et al. Spirometric criteria for asthma: adding further evidence to the debate. J Allergy Clin Immunol 2005, 116(5):976-982.
51. Miranda C., Busacker A., Balzar S., et al. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 2004, 113(1):101-108.
52. Cocchi F., DeVico A.L., Garzino-Demo A., et al. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995, 270(5243):1811-1815.
53. Centers for Disease Control and Prevention (CDC) Cigarette smoking among adults-United States, 2004. MMWR Morb Mortal Wkly Rep 2005, 54(44):1121-1124.
54. Crothers K., Goulet J.L., Rodriguez-Barradas M.C., et al. Decreased awareness of current smoking among health care providers of HIV-positive compared to HIV-negative veterans. J Gen Intern Med 2007, 22(6):749-754.
55. Crothers K., Griffith T.A., McGinnis K.A., et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med 2005, 20(12):1142-1145.
56. Helleberg M., Afzal S., Kronborg G., et al. Mortality attributable to smoking among HIV-1-Infected Individuals: a nationwide, population-based cohort study. Clin Infect Dis 2013, 56(5):727-734.
57. Cummins D., Trotter G., Moussa M., et al. Smoking cessation for clients who are HIV-positive. Nurs Stand 2005, 20(12):41-47.
58. Vidrine D.J., Arduino R.C., Lazev A.B., et al. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS 2006, 20(2):253-260.
59. Wewers M.E., Neidig J.L., Kihm K.E. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. J Assoc Nurses AIDS Care 2000, 11(6):37-44.
60. Ferketich A.K., Diaz P., Browning K.K., et al. Safety of varenicline among smokers enrolled in the Lung HIV Study. Nicotine Tob Res 2013, 15(1):247-254.
61. Calverley P.M., Anderson J.A., Celli B., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356(8):775-789.
62. Brassard P., Suissa S., Kezouh A., et al. Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases. Am J Respir Crit Care Med 2011, 183(5):675-678.
63. Hirschtick R.E., Glassroth J., Jordan M.C., et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med 1995, 333(13):845-851.
64. Segal L.N., Methe B.A., Nolan A., et al. HIV-1 and bacterial pneumonia in the era of antiretroviral therapy. Proc Am Thorac Soc 2011, 8(3):282-287.
65. Foisy M.M., Yakiwchuk E.M., Chiu I., et al. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Med 2008, 9(6):389-396.
66. Kaviani N., Bukberg P., Manessis A., et al. Iatrogenic osteoporosis, bilateral hip osteonecrosis, and secondary adrenal suppression in an HIV-infected patient receiving inhaled corticosteroids and ritonavir-boosted HAART. Endocr Pract 2011, 17(1):74-78.
67. Kedem E., Shahar E., Hassoun G., et al. Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient. J Asthma 2010, 47(7):830-831.
68. Oursler K.K., Goulet J.L., Leaf D.A., et al. Association of comorbidity with physical disability in older HIV-infected adults. AIDS Patient Care STDS 2006, 20(11):782-791.
69. Oursler K.K., Goulet J.L., Crystal S., et al. Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the Veterans Aging Cohort Study. AIDS Patient Care STDS 2011, 25(1):13-20.
70. Nici L., Donner C., Wouters E., et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006, 173(12):1390-1413.
71. Authier F.J., Chariot P., Gherardi R.K. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). Muscle Nerve 2005, 32(3):247-260.
72. Oursler K.K., Sorkin J.D., Smith B.A., et al. Reduced aerobic capacity and physical functioning in older HIV-infected men. AIDS Res Hum Retroviruses 2006, 22(11):1113-1121.
73. Schulz L., Nagaraja H.N., Rague N., et al. Respiratory muscle dysfunction associated with human immunodeficiency virus infection. Am J Respir Crit Care Med 1997, 155(3):1080-1084.
74. Nixon S., O'Brien K., Glazier R.H., et al. Aerobic exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev 2010, (8). CD001796.
75. O'Brien K., Nixon S., Glazier R.H., et al. Progressive resistive exercise interventions for adults living with HIV/AIDS. Cochrane Database Syst Rev 2004, (4). CD004248.
76. Coultas D.B., Mapel D., Gagnon R., et al. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. Am J Respir Crit Care Med 2001, 164(3):372-377.
77. Sin D.D., McAlister F.A., Man S.F., et al. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003, 290(17):2301-2312.
78. Tomas L.H., Varkey B. Improving health-related quality of life in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2004, 10(2):120-127.